Carboxymethylcellulose sodium
As of the edition of 20 October 2026, Carboxymethylcellulose sodium is a drug: marketed, first approved in 1991 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1991
- Kind
- Unknown
- Brand name
- Refresh Celluvisc
- First approved
- 31 December 1991 (CA)
- Approvals on record
- 9 in 1 region
- Holder of the most recent approval
- AbbVie; 2 holders in all
- Registered trials
- 2, 0 stopped early
- Disease areas
- Eye
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase 3 | 1 | 1 | 0 | 0 |
| Phase 4 | 1 | 1 | 0 | 0 |
| All trials | 2 |